Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fully agreed Cents! It is incredible that we have Dr. Marincola on $TSOI’s SAB. Shows that $TSOI has a great scientific team with world renowned and recognized specialists, researchers and scientists working with and guiding $TSOI to the forefront of this breakthrough technology to address most, if not all, top health issues in the world!
Go $TSOI!
We have to remember that the $100mill profit will be split between Q4-2020 and Q1-2021, as far as the financial reporting goes. So, the pps rise will be incremental to $1 based on Q over/to Q increases in revenues. I prefer this way as IMO, it shows continuous and on-going growth and helps support the pps gains.
Just my thoughts!
Long and strong $OPTI!
$tsoi SAB member news. Could be a great connection between $tsoi and Kite pharma!
January 19, 2021
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
-- Research Veteran Brings More than 30 Years of Industry and NIH Experience to Kite Leadership Team --
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite, a Gilead Company (Nasdaq: GILD), today announced that Francesco Marincola, MD, will join the company as Senior Vice President and Global Head of Cell Therapy Research, effective February 1. Dr. Marincola will lead Kite’s Research organization across hematological malignancies and solid tumors.
Our patience and long waiting will pay off!
Go $celz!
75 mil vol.
Go $CELZ
I saw that! And CDEL AND ETRF (or the sellers going thru them) need to get off the ASK and let it run! Or at the least, break down the ASKs into smaller units!
But, we will run. Just a matter of time!
Go $TSOI!
Fantastic News!
Go go go $tsoi!
Additionally, if you are indicating that Dr. Dre will look to participate in a trial related to Brain, $celz is not involved in that - Dr. Dre needs to go to $tsoi for that. $tsoi holds the licensing agreements for Jadicells for Brain related injurues - tbi/cte.
Are you trying to say that Dr. Dre will try and participate in the ImmCelz trials? What is 3rd arm?
Thanks for sharing! Astronomical growth!
Boom! Go $OPTI
$OPTI NEWS!,!,
OPTEC International, Inc. Acquires Z2O the Uber "App" of On-Demand Cleaning & Disinfecting Services
Source: InvestorsHub NewsWire
OPTEC International, Inc. Acquires Z2O the Uber “App” of On-Demand Cleaning & Disinfecting Services
CARLSBAD, CA -- January 14, 2021 -- InvestorsHub NewsWire -- OPTEC International, Inc. (OTC Pink: OPTI), a developer of UV and UV-C safety products using related advanced technologies specific to Personal Protection Equipment (PPE), today announced the acquisition of Z2O; a dynamic new Uber Type proprietary “App” for on-demand 24/7cleaning and disinfecting services, using smart device technology for immediate service responses nationwide and ultimately worldwide, scheduled to launch March 1st, 2021.
About Z2O
During these challenging times, there is a vital need to protect businesses and homes from harmful bacteria, viruses, and everything in between. Z2O is a new, app based, on-demand network, delivering an effortless way to schedule cleaning and disinfecting services using smart devices, at the same time providing existing companies and starts ups new opportunities to create jobs and operate and expand business services. This is the Uber of cleaning and disinfecting, offering the opportunity for the local workforce to have the ability to generate income for essential services that will help their local community as well as expand job opportunities for their employees and staff.
Available 24/7, Z2O provides a fast, efficient way to schedule one-time or recurring services at home or at work - all with a single click.
Services include home and real estate, businesses and restaurants, schools and childcare, fitness centers and gyms, hotels, senior care facilities, airports, and public service areas, and much more.
Users of the Z2O on-demand app have the ability to request services with confidence knowing that Z2O uses a scrupulous background check process to ensure the utilization of safe and reliable professionals to administer services.
Z2O plans to launch a pilot program in Austin, Texas on March 1, 2021and will expand to other major US cities shortly thereafter.
Visit the Z2O website at www.z2o.com for more information including app download, how to schedule services, and how to become a vendor starting March 1st, 2021.
The Z2O App downloads will be available for both consumers and service providers starting March 1, 2021.
Optec International CEO, Roger Pawson, stated “We are very excited to have completed this acquisition, which has been in negotiations since August 2020. Optec is ready to fully launch the Z2O program commencing March 1st which is expected to rapidly expand across the country as the need for these services increase at a phenomenal rate as the pandemic reaches record levels. We believe the demand for these services using the Z2O app technology will surpass our projected expectations adding new highs to the company’s revenues and profitability”.
That is simply beautiful!
Go $OPTI!
Let them sell and go! IMO selling today is silly, with so much more news to come! And the true volume has not come in yet!
I’m holding long and strong!
Go $OPTI!
Boom ??!
Go $opti!
Time to rise and shine!
Go $celz!
999
Let’s goooooooo! $OPTI!
0.099
Go $Opti!
Hey guys/gals! Me too! Been here for 2+ years.
Still holding! Avg’d down quite a bit, but still in the teens.
We will get there. Not worried!
Go $celz!
Looks fantastic! Gapping up this morning!
Go $OPTI!
What ever few I have, I’m holding till the end!
Go $ALPP!
What a come back!
Go $ALPP!
why $TSOI created the CNSI division, ?.?
Any ideas...??
Because it will be easier to................?
Ha ha ha!
Go $TSOI!
You can tell - it’s dying to run!
Let her loose!!!!!
Go $TSOI!
Awesome gint! Thanks for sharing.
Time for $celz to fly!
Go $CELZ!
The progress $tsoi made in the last months, let alone the whole year, of 2020 is insane, incredible, and unbelievable!
New year, new month, new week, and a new page in the books of $tsoi.
Let’s get ready to rock the world in Q1 and rest of 2021.
Go $tsoi!
Thanks Moby! Appreciate ur response.
I’m long on $IBRC as well and wanted to make sure i didn’t get kicked out.
Same to you doog.
Happy New Year!
No to Fidelity and no to Morgan Stanley.
Hey guys, what Financial Institution are you guys using to buy/sell/hold $IBRC?
I am using TDA and got notified that they will liquidate all ‘caveat Emptor’ shares mid January!
I need to move my shares or buy using another Financial institution to maintain my position here.
Any input would be greatly appreciated!
Run, Forest Run!
Go $Opti!
You bet! Fantastic News!
As we have always discussed, this is a stock for the long term. Excellent IP, great research and fantastic people coming together to build a sustainable business around cutting edge science and technology!
Go $tsoi! To the moon!
More news! Ka ka ka ka kaboom!
Go $tsoi!
c))
Item 1.01 Entry into a Material Definitive Agreement
On December 21, 2020, Therapeutic Solutions International, Inc.’s (the “Company”) wholly owned subsidiary Sandbox Dental Labs, Inc., formally changed its name to Campbell Neurosciences, Inc. Subsequently, a number of unanimous written consents and recorded board minutes followed the name change to restructure Campbell Neurosciences, Inc., and are included here in exhibit 10.1 to 10.6. Following the restructuring of Campbell Neurosciences, Inc., the Company entered into a purchase agreement and nine exclusive patent license agreements included here in exhibit 10.7 to 10.16 with Campbell Neurosciences, Inc.
Item 8.01 Other Events.
The information set forth in Item 1.01 of this Current Report on Form 8-K regarding the change of name and restructure is incorporated herein by reference including reference to exhibits.
Item 9.01 Financial Statements and Exhibits.
Exhibit Index
(10.1)
Unanimous written consent of the Board of Directors of Sandbox Dental Labs, Inc.
(10.2)
Unanimous written consent of the Board of Directors of Therapeutic Solutions International, Inc.
(10.3)
Unanimous written consent of the Board of Directors of Sandbox Dental Labs, Inc.
(10.4)
Unanimous written consent of the Board of Directors of Campbell Neurosciences, Inc.
(10.5)
Minutes of the Board of Directors of Campbell Neurosciences, Inc.
(10.6)
Minutes of the Board of Directors of Campbell Neurosciences, Inc.
(10.7)
Purchase Agreement between TSOI and CNSI
(10.8)
Exclusive Patent License Agreement between TSOI and CNSI 17-030416
(10.9)
Exclusive Patent License Agreement between TSOI and CNSI 63-057315
(10.10)
Exclusive Patent License Agreement between TSOI and CNSI 63-061202
(10.11)
Exclusive Patent License Agreement between TSOI and CNSI 63-068388
(10.12)
Exclusive Patent License Agreement between TSOI and CNSI 63-071381
(10.13)
Exclusive Patent License Agreement between TSOI and CNSI 63-077723
(10.14)
Exclusive Patent License Agreement between TSOI and CNSI 63-105964
(10.15)
Exclusive Patent License Agreement between TSOI and CNSI 63-122862
(10.16)
Exclusive Patent License Agreement between TSOI and CNSI 63-128759
Getting super close!
Time to load/add.
Go $TSOI
Not true, my friend. All those shares are restricted and they all require some pathway through rule 144 or an exemption like S-1,3,8
So............???
Go $tsoi!
$tsoi News!
Therapeutic Solutions International Reports QuadraMune™ Increases T Cell Immunity in Animal Studies
Accumulating Data Supports Possibility of Enhanced Antiviral Immunity Using Nutraceutical Approach
NEWS PROVIDED BY
Therapeutic Solutions International
Dec 30, 2020, 09:30 ET
SHARE THIS ARTICLE
OCEANSIDE, Calif., Dec. 30, 2020 /PRNewswire/ -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data demonstrating a two-week course of QuadraMune™ increased immunological parameters relevant to antiviral immunity.
In a series of experiments, the Company demonstrated that animals injected with a model antigen, keyhole limpet hemacyanin (KLH) possessed a significantly enhanced T cell response. The type of T cell response that was preferentially elicited in animals taking QuadraMune was associated with interferon gamma, a protein known to inhibit viral replication.
"Previously we have demonstrated that QuadraMune is associated with enhanced natural killer cells, which represent the innate arm of the immune system" said Dr. James Veltmeyer, Chief Medical Officer of the Company. "The demonstration that the adaptive immune response is also enhanced by QuadraMune, provides further rationale for evaluation of this nutraceutical as a preventative for COVID-19."
The Company is currently running a clinical trial in health care workers using QuadraMune to prevent COVID-19 infection. More information on the clinical trial can be found on the Federal Clinical Trials registry as #NCT04421391.
"Although there are numerous nutraceutical products on the market that claim to boost immunity, I am extremely proud that we as a company are differentiating ourselves by conducting scientific experiments to objectively validate our approach" said Famela Ramos, Vice President of Business Development.
"Our Company is based on utilizing the immune system to treat numerous chronic and degenerative conditions. Today's findings, that QuadraMune stimulates the Th1 arm of the immune system, suggests that QuadraMune may be useful for other conditions associated with immune dysregulation" said Timothy Dixon, President and CEO of the Company. "It is believed that Th1 immunity is useful not only in the treatment of viruses but also in eradication of cancer and intracellular bacterial."
You bet! Added and locked them up!
Go $TSOI!
Same here! But, already positive on the buy! So, all is good!
Added at 0.005. And locked them up!
Go $TSOI!
Go go $celz! Fantastic News today! Setting up the launching pad for 2021.
Go $CELZ!
Up Pre- Market! And it is early!
Let’s go $OPTI!